TY  - JOUR
AU  - Vela, Maria
AU  - Bueno, David
AU  - González-Navarro, Pablo
AU  - Brito, Ariadna
AU  - Fernandez, Lucia
AU  - Escudero, Adela
AU  - Valentín, Jaime
AU  - Mestre-Durán, Carmen
AU  - Arranz-Álvarez, Marina
AU  - Pérez de Diego, Rebeca
AU  - Mendiola, Marta
AU  - Pozo-Kreilinger, José Juan
AU  - Pérez-Martínez, Antonio
PY  - 2019
DO  - 10.3389/fimmu.2019.01814
SN  - 1664-3224
UR  - http://hdl.handle.net/20.500.12105/9345
AB  - Sarcoma is one of the most severe forms of pediatric cancer and current therapies -chemotherapy and surgery- fail to eradicate the disease in half of patients. Preclinical studies combining new therapeutic approaches can be useful to design better...
LA  - eng
PB  - Frontiers Media
KW  - Activated and expanded natural killer (NKAE) cells
KW  - Chemokine C-X-C receptor 4 (CXCR4)
KW  - Immunotherapy
KW  - Metastasis
KW  - Sarcoma
KW  - Therapeutic antibody
TI  - Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy
TY  - journal article
ER  -